Word

COMPLETE

Status

Registered

Status Code

700

Status Date

Tuesday, May 16, 2023

Serial Number

97354349

Registration Number

7054865

Registration Date

Tuesday, May 16, 2023

Mark Type

4000

Filing Date

Friday, April 8, 2022

Published for Opposition

Tuesday, February 28, 2023

Trademark Owner History

AbbVie Biotechnology Ltd - Original Registrant

Classifications

41 Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments thereof

42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites

Trademark Events

May 16, 2023

Notice Of Registration Confirmation Emailed

May 16, 2023

Registered-Principal Register

Feb 28, 2023

Official Gazette Publication Confirmation E-Mailed

Feb 28, 2023

Published For Opposition

Feb 8, 2023

Notification Of Notice Of Publication E-Mailed

Jan 23, 2023

Approved For Pub - Principal Register

Dec 29, 2022

Teas/Email Correspondence Entered

Dec 28, 2022

Correspondence Received In Law Office

Dec 28, 2022

Teas Response To Office Action Received

Jul 1, 2022

Notification Of Non-Final Action E-Mailed

Jul 1, 2022

Non-Final Action E-Mailed

Jul 1, 2022

Non-Final Action Written

Jun 27, 2022

Assigned To Examiner

Apr 13, 2022

New Application Office Supplied Data Entered

Apr 12, 2022

New Application Entered